The CXCR3 antagonist NBI-74330 alleviates neuroimmune dysfunction by lowering pro-inflammatory mediator signaling in CD45+ cells of BTBR T+ Itpr3tf/J mice

Introduction Autism Spectrum Disorder (ASD) is a neurodevelopmental condition that affects social interaction and communication and is often accompanied by stereotyped behaviors. This study examined the effects of the CXCR3 antagonist NBI-74330 on BTBR T+ Itpr3tf/J (BTBR), an autistic mouse model. Recent research suggests that NBI-74330, a CXCR3 antagonist, could have therapeutic benefits in inflammatory and neurodegenerative diseases. Methods We examined NBI-74330's effects on social behavior, self-grooming, and marble burying in BTBR mice. We also evaluated its impact on IFN-γ, T-bet, IL-17A, RORγt, STAT3, IL-22, and AhR levels in CD45 + spleen cells. We measured mRNA levels of these inflammatory mediators in brain tissue. Results Results showed that NBI-74330 significantly improved social interactions and decreased self-grooming and marble-burying behaviors in BTBR mice without affecting arousal, anxiety, or locomotion. Immunological analysis showed marked reductions in CD45 + IFN-γ + , CD45 + T-bet + , CD45 + IL-17A + , CD45 + RORγt + , CD45 + STAT3 + , CD45 + IL-22 + , and CD45 + AhR + cells. NBI-74330-treated BTBR mice exhibited lower mRNA levels of these proinflammatory mediators. Discussion These findings suggest that NBI-74330 can reduce behavioral abnormalities and immune dysregulation in BTBR mice. To our knowledge, this is the first evidence supporting the potential of the CXCR3 antagonist NBI-74330 as a therapeutic option for autism-like symptoms.

Authors

Institutions

Publication Details

Journal
Frontiers in Psychiatry
Published
2026-11-13
DOI
https://doi.org/10.3389/fpsyt.2026.1971064
Primary Topic
Autism Spectrum Disorder Research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

The CXCR3 antagonist NBI-74330 alleviates neuroimmune dysfunction by lowering pro-inflammatory mediator signaling in CD45+ cells of BTBR T+ Itpr3tf/J mice

Abdullah S. Alhamed, Saleh A. Bakheet, Hussain N. Alhamami, Mushtaq Ahmad Ansari et al.
Frontiers in Psychiatry
Autism Spectrum Disorder Research
article

The CXCR3 antagonist NBI-74330 alleviates neuroimmune dysfunction by lowering pro-inflammatory mediator signaling in CD45+ cells of BTBR T+ Itpr3tf/J mice

Abdullah S. Alhamed, Saleh A. Bakheet, Hussain N. Alhamami, Mushtaq Ahmad Ansari, Abdulaziz M. S. Alsaad, Haneen A. Al‐Mazroua, Hatun A. Alomar, Alaa A. Alanteet, Ahmed Nadeem, Sabry M. Attia, Sheikh F. Ahmad
article en

Abstract

Introduction Autism Spectrum Disorder (ASD) is a neurodevelopmental condition that affects social interaction and communication and is often accompanied by stereotyped behaviors. This study examined the effects of the CXCR3 antagonist NBI-74330 on BTBR T+ Itpr3tf/J (BTBR), an autistic mouse model. Recent research suggests that NBI-74330, a CXCR3 antagonist, could have therapeutic benefits in inflammatory and neurodegenerative diseases. Methods We examined NBI-74330's effects on social behavior, self-grooming, and marble burying in BTBR mice. We also evaluated its impact on IFN-γ, T-bet, IL-17A, RORγt, STAT3, IL-22, and AhR levels in CD45 + spleen cells. We measured mRNA levels of these inflammatory mediators in brain tissue. Results Results showed that NBI-74330 significantly improved social interactions and decreased self-grooming and marble-burying behaviors in BTBR mice without affecting arousal, anxiety, or locomotion. Immunological analysis showed marked reductions in CD45 + IFN-γ + , CD45 + T-bet + , CD45 + IL-17A + , CD45 + RORγt + , CD45 + STAT3 + , CD45 + IL-22 + , and CD45 + AhR + cells. NBI-74330-treated BTBR mice exhibited lower mRNA levels of these proinflammatory mediators. Discussion These findings suggest that NBI-74330 can reduce behavioral abnormalities and immune dysregulation in BTBR mice. To our knowledge, this is the first evidence supporting the potential of the CXCR3 antagonist NBI-74330 as a therapeutic option for autism-like symptoms.

Frontiers in PsychiatryVol. 17
King Saud University (SA)
King Saud University
Good health and well-being
Autism Spectrum Disorder Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon